NHS North Thames Genomic Medicine Service (GMS) Alliance
The NHS North Thames Genomic Medicine Service (GMS) Alliance is one of seven alliances launched by NHS England in January 2021, created to support the systematic implementation of genomic medicine into the mainstream healthcare system and harness the power of genomics to improve the health of our population.
Through the work of the Alliances, the NHS will become the first health service in the world to embed genomics into routine care and make significant strides to create a system focused on improving health, not just by treating illness, but by better understanding the underlying cause, enabling more accurate prediction of disease and tailoring of treatments to individuals.
The North Thames GMS Alliance will work with all healthcare providers, patients and the public to build trust in genomics and support the multi-professional workforce to use genomics safely, effectively and efficiently.
By embedding genomics into the mainstream health service, the North Thames GMS Alliance aims to deliver improvements for patients including better, quicker diagnosis of rare conditions, personalising treatment and care for those with inherited conditions and cancer, and building a better understanding of the underlying cause of many conditions.
About our Alliance
We are a partnership across North East, Central and West London health and care partners, including Trusts in West Hertfordshire and Mid and South Essex.
Our alliance brings together multi-disciplinary clinical leadership, including physicians, nurses, midwives, clinical scientists and pharmacists working in both primary and secondary care, Cancer Alliances, research and academia. We work closely with the North Thames Genomic Laboratory Hub (GLH), led by Great Ormond Street NHS Foundation Trust, who are responsible for providing genomic and genetic testing in our region, including the start of whole genome sequencing as part of the new genomic medicine service in the NHS.
Through our work, the Alliance will collaborate to provide consistent and accessible genetic and genomic testing for a large and diverse population of around 10 million people, combining clinical capabilities, expertise in patient and public involvement, community outreach and an excellent track record in research to achieve a step change in delivering genomic medicine for our population.
The North Thames GMS Alliance is hosted by UCLPartners and supported by Imperial College Health Partners. We are led by the Clinical Director, Dr Francesca Faravelli.
To hear Dr Francesca Faravelli’s thoughts on how the North Thames GMS Alliance will bring the benefits of genomics to patients you can read her blog: “Genomics – from the classroom to mainstream patient care”.
For further information on the North Thames GMS Alliance, please contact email@example.com.